Needham & Company
-
Today's most important upgrades
-
Masimo Corp. (MASI) PT Lowered to $163 at Needham & Company
-
UPDATE: Needham & Company Upgrades Masimo Corp. (MASI) to Buy
-
Masimo to Present in 20th Annual Needham Healthcare Conference
-
Masimo Announces Limited Market Release of Radius VSM™
-
Needham & Company Downgrades Masimo Corp. (MASI) to Hold
-
Masimo Corp. (MASI) Announces FDA Clearance of Radius PPG
-
Masimo Announces FDA Clearance of Radius PPG™, the First Tetherless SET® Pulse Oximetry Sensor Solution
-
Masimo Corp. (MASI) PT Raised to $158 at Needham & Company
-
Masimo to Present at 18th Annual Needham Healthcare Conference
-
Masimo Corp. (MASI ) PT Raised to $155 at Needham & Company On Opiod Device Potential
-
Masimo Corp. (MASI) PT Raised to $148 at Needham & Company
-
Needham & Company Starts Masimo Corp. (MASI) at Buy
-
Leading Ohio Critical Access Hospital Adopts Masimo Root® with Radius-7®, Radical-7®, and Patient SafetyNet™ to Create Hospital-Wide Wireless Monitoring and Clinician Notification System
-
Masimo's (MASI) Radius-7 Receives FDA 510(k) Clearance
-
Masimo's (MASI) Radius-7 Receives FDA 510(k) Clearance
-
Masimo Announces FDA 510(k) Clearance for Radius-7® with rainbow® Technology, Including Continuous SpHb®
-
Masimo Root Wins the GOLD 2015 Medical Design Excellence Award
-
Masimo to Showcase Root(R) Solutions for the OR and ICU at the International Anesthesia Research Society's 2015 Annual Meeting and International Science Symposium
-
Masimo Corp's (MASI) Radius-7 Receives FDA 510(k) Clearance